Anti-neoplastic agent thymoquinone induces degradation of α and β tubulin proteins in human cancer cells without affecting their level in normal human fibroblasts-Reference-Cited by-同舟云学术

Anti-neoplastic agent thymoquinone induces degradation of α and β tubulin proteins in human cancer cells without affecting their level in normal human fibroblasts

Published:2011-09-01 Issue:5 Volume:30 Page:1813-1819
ISSN:0167-6997
Container-title:Investigational New Drugs
language:en
Short-container-title:Invest New Drugs

Author:

Alhosin Mahmoud,Ibrahim Abdulkhaleg,Boukhari Abdelaziz,Sharif Tanveer,Gies Jean-Pierre,Auger Cyril,Schini-Kerth Valérie B.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10637-011-9734-1.pdf

Reference44 articles.

1. Zhou J, Giannakakou P (2005) Targeting microtubules for cancer chemotherapy. Curr Med Chem Anticancer Agent 5:65–71. doi: 10.2174/1568011053352569

2. Jordan MA, Wilson L (2004) Microtubules as a target for anticancer drugs. Nat Rev Cancer 4:253–265. doi: 10.1038/nrc1317

3. Dumontet C, Jordan MA (2010) Microtubule-binding agents: a dynamic field of cancer therapeutics. Nat Rev Drug Discov 9:790–803. doi: 10.1038/nrd3253

4. Huisman MT, Chhatta AA, van Tellingen O, Beijnen JH, Schinkel AH (2005) MRP2 (ABCC2) transports taxanes and confers paclitaxel resistance and both processes are stimulated by probenecid. Int J Cancer 116:824–829. doi: 10.1002/ijc.21013

5. Hopper-Borge E, Chen ZS, Shchaveleva I, Belinsky MG, Kruh GD (2004) Analysis of the drug resistance profile of multidrug resistance protein 7 (ABCC10): resistance to docetaxel. Cancer Res 64:4927–4930. doi: 10.1158/0008-5472.CAN-03-3111

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design, synthesis and biological evaluation of novel tubulin-targeting agents with a dual-mechanism for polymerization inhibition and protein degradation;European Journal of Medicinal Chemistry;2024-06

2. The Emerging Role of Natural Products in Cancer Treatment;Archives of Toxicology;2024-05-25

3. The Potential Strategies for Overcoming Multidrug Resistance and Reducing Side Effects of Monomer Tubulin Inhibitors for Cancer Therapy;Current Medicinal Chemistry;2024-04

4. Exploring the Potential of Phytochemicals Derived From Indian Medicinal Plants for Management and Treatment of Glioblastoma Multiforme Based on In Vitro Studies;Journal of Herbal Medicine;2024-03

5. Novel 4-Aryl-4H-chromene derivative displayed excellent in vivo anti-glioblastoma efficacy as the microtubule-targeting agent;European Journal of Medicinal Chemistry;2024-03